Open Access

A comprehensive gene mutation analysis of liquid biopsy samples from patients with metastatic colorectal cancer to the ovary: A case report

  • Authors:
    • Naoyuki Iwahashi
    • Kazuko Sakai
    • Tomoko Noguchi
    • Tamaki Yahata
    • Saori Toujima
    • Kazuto Nishio
    • Kazuhiko Ino
  • View Affiliations

  • Published online on: September 20, 2018     https://doi.org/10.3892/ol.2018.9467
  • Pages: 6431-6436
  • Copyright: © Iwahashi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Liquid biopsies of circulating tumor DNA (ctDNA) can detect molecular alterations, including tumor‑specific mutations, and have recently been used as a non‑invasive diagnostic, prognostic, and predictive tool. However, this technique is not commonly used in the gynecological field. Gene mutation profiling of liquid biopsy samples was performed using CAncer Personalized Profiling by deep Sequencing (CAPP‑Seq), a novel next‑generation sequencing‑based approach to ultrasensitive ctDNA detection, in order to make it possible to molecularly diagnose metastatic colorectal cancer to the ovary. Liquid biopsy (plasma) samples and formalin‑fixed paraffin‑embedded tumor samples were obtained from two patients with ovarian tumors, who had a history of surgery for colorectal cancer, and comprehensive gene mutation profiling was conducted using CAPP‑Seq. In patient 1, mutations were identified in the same three regions in both the ovarian tumor and preoperative plasma sample (in the KRAS G13D, APC E1306*, and TP53 H193Y genes). In patient 2, mutation was identified in the same one region in all the primary colorectal tumor, the ovarian tumor, and preoperative plasma sample (in APC R216* gene). These mutations are well‑known genetic signatures of colorectal cancer, suggesting that the ovarian tumor was metastatic. Tthe gene mutation patterns of colorectal cancer were examined by subjecting liquid biopsy samples from patients with suspected metastatic ovarian tumors to CAPP‑Seq. Gene mutation profiling of liquid biopsy samples can contribute to the preoperative differential diagnosis of metastatic ovarian cancer and its subsequent personalized treatment.
View Figures
View References

Related Articles

Journal Cover

November-2018
Volume 16 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Iwahashi N, Sakai K, Noguchi T, Yahata T, Toujima S, Nishio K and Ino K: A comprehensive gene mutation analysis of liquid biopsy samples from patients with metastatic colorectal cancer to the ovary: A case report. Oncol Lett 16: 6431-6436, 2018.
APA
Iwahashi, N., Sakai, K., Noguchi, T., Yahata, T., Toujima, S., Nishio, K., & Ino, K. (2018). A comprehensive gene mutation analysis of liquid biopsy samples from patients with metastatic colorectal cancer to the ovary: A case report. Oncology Letters, 16, 6431-6436. https://doi.org/10.3892/ol.2018.9467
MLA
Iwahashi, N., Sakai, K., Noguchi, T., Yahata, T., Toujima, S., Nishio, K., Ino, K."A comprehensive gene mutation analysis of liquid biopsy samples from patients with metastatic colorectal cancer to the ovary: A case report". Oncology Letters 16.5 (2018): 6431-6436.
Chicago
Iwahashi, N., Sakai, K., Noguchi, T., Yahata, T., Toujima, S., Nishio, K., Ino, K."A comprehensive gene mutation analysis of liquid biopsy samples from patients with metastatic colorectal cancer to the ovary: A case report". Oncology Letters 16, no. 5 (2018): 6431-6436. https://doi.org/10.3892/ol.2018.9467